SCHEMBL16708555

SCHEMBL16708555

[N-]=[N+]=N[C@]1(CO)O[C@@H](c2cc(F)c3c(N)ccnn23)[C@H](F)[C@@H]1O

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16699053 0.87 POLRMT (0.40) POLRMT
SCHEMBL20756371 0.87 POLRMT (0.40) POLRMT
SCHEMBL23959993 0.78 POLRMT (0.48) POLRMT
SCHEMBL20756076 0.74 POLRMT (0.57) POLRMT
SCHEMBL16698968 0.74 POLRMT (0.57) POLRMT
SCHEMBL16710426 0.74 POLRMT (0.53) POLRMT
SCHEMBL20756115 0.74 POLRMT (0.41) POLRMT
SCHEMBL16698792 0.74 POLRMT (0.41) POLRMT
SCHEMBL13486320 0.74 POLRMT (0.43) POLRMT
SCHEMBL13486313 0.72 POLRMT (0.38) POLRMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9388208-B2 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections GILEAD SCIENCES, INC. (US) 2016-07-12 — — US disclosed
US-20150133395-A1 PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS ROSEMOUNT INC. 2015-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150133395-A1 PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS SYNJ1, SARS1, SYNJ2 POLRMT 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback